Afinitor
Active substance: everolimus
TABLET · EVEROLIMUS 2.5 mg/1
United StatesActive
Marketing holder: Novartis Pharmaceuticals Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- EVEROLIMUS · 2.5 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 28 |
|
| EU 2 |
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e21-77c3-86ab-8310c3f7f66b,01a120c3-38fe-7e7e-88ef-47e775eff9c8,01a120c3-4cd4-7c11-b529-1b219b393c6d,01a120c3-4f5d-727f-85b4-669a46205274,01a120c3-54db-749a-bbcf-a17fb8015cfd;count=26 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-44d0-7e6c-9aed-05b6eb240d04,01a1208c-45c4-7a49-97f0-46e7236a4cd7,01a1208c-6599-7100-9ffb-76c35ab9b6c0,01a1208c-721e-73bb-bd89-7e15a8608237,01a1208c-8270-7d32-8813-791e265f90ed;count=98 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0078-0594
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 0078-0594 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0078-0594 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0078-0594 · Verified 2026-10-09 · open in source